Gabapentin administration tips
How owners can administer doses safely.
Roxee Medication Guide
Gabapentin
Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.
Both
Reference partial
Not FDA-approved for animals
Multiple FDA labelers
Official label facts
Owner quick guide first
Veterinary professional?
Showing simplified owner view. Switch to Vet View for full technical detail.
Some reference facts for this medication are still being verified.
Not FDA-approved as an animal drug.
No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.
Do not start, stop, or change treatment without your veterinarian.
Data freshness
Reference facts
Reference refreshed
Aug 6, 2026, 7:47 p.m.
Roxee has a partial reference profile for this medication. Some primary facts still need verification.
FDA applications
FDA application data refreshed
Aug 6, 2026, 7:47 p.m.
Sponsor, product, and application records imported from Animal Drugs @ FDA.
Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.
openFDA reaction terms and case summaries are supporting evidence, not proof of causality.
Source timing details
Source timing details
-
Reference facts:
Source Roxee
| Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Aug 6, 2026, 7:47 PM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Gabapentin
Gabapentin
Drug type: Generic ingredient • Branded profile • Not FDA-approved for animals
Both
86% reference complete
Species: Both
Approval status: Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.
Medication Snapshot
Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.
Gabapentin
Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases. Species commonly shown: Both.
Generic name
Gabapentin
Brand names
GABAPENTIN, SolutitionKits
Manufacturer
Multiple FDA labelers
Species
Both
Completeness
86%
Validation
Incomplete
Brand names
GABAPENTIN
SolutitionKits
Indications / Uses
Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.
Administration / How To Give
Oral
Storage
Store at room temperature.
Warnings / Contraindications
Use caution with kidney disease; dose adjustments may be needed.
- Use caution with kidney disease; dose adjustments may be needed.
Side Effects
Sedation, ataxia, mild GI upset.
FAQ
Both
Store at room temperature.
Related Medications
Related Conditions
Source Transparency
- Verified source: https://www.roxee.ai/meds/
- Verified source: https://animaldrugsatfda.fda.gov
- Verified source: https://animaldrugsatfda.fda.gov/adafda/views/#/search
- Verified source: https://api.fda.gov/animalandveterinary/event.json
- Verified source: https://www.roxee.ai/conditions/
- Verified source: /static/meds/images/gabapentin.jpg
- Last refreshed: Aug 6, 2026, 7:47 p.m.
- Last verified: Apr 15, 2026, 10:04 a.m.
- Validation status: Incomplete
Add to My Pet's Medications
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continueVideos
Video education and manufacturer materials for Gabapentin.
Educational Videos
Manufacturer Videos
Gabapentin manufacturer spotlight
Promotional
Disclosure:
Manufacturer-linked promotional content. Educational sections should be prioritized for clinical context.
Manufacturer-provided informational segment.
Pet Owner Quick Guide
Start here first for the safest next-step summary before the deeper medication detail.
Used for:
Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.
Dosing note:
Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.
What to watch for:
- Use caution with kidney disease
- dose adjustments may be needed
- Thrombocytopenia (4 reports)
- Elevated symmetrical dimethylarginine (4 reports)
- Conjunctivitis (3 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
What to tell or ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Research brief
Medication Research Insights
A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.
What to know
Evidence-backed context
Limited
Roxee has limited cited overview evidence for Gabapentin; use the official documents and your veterinarian's instructions for product-specific decisions.
Source: openFDA reaction aggregate term
Safety signal coverage
Reported signals
32 tracked reaction signals; 60 reported cases; 7 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.
Source: openFDA reaction aggregate term
Interpretation guardrail
Not causation
Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.
Evidence tension
Stronger signal
Label / review
Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.
Source: openFDA reaction aggregate term
Weaker signal
Reported data
Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.
Reaction signal map
Most reported reactions
Top terms
Thrombocytopenia (4 reports), Elevated symmetrical dimethylarginine (4 reports), Conjunctivitis (3 reports), Urolithiasis (2 reports), Unclassifiable adverse event (2 reports)
Body systems represented
Signal grouping
Effectiveness (1), Other (31)
Species and breed lens
Species represented in reports
Species lens
Dog (48 reports), Cat (12 reports)
Breed metadata in reports
Metadata only
Domestic Shorthair (2), Retriever - Labrador (2), Schnauzer - Miniature (1), Crossbred Canine/dog (1). These are report metadata, not proof that a breed is at higher risk.
What your vet may verify
Fit for this patient
Vet check
Verify whether Gabapentin fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.
Evidence limitations
Evidence review
Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.
What to watch next
Watch list
Owner-safe
Use caution with kidney disease, dose adjustments may be needed, Thrombocytopenia, Elevated symmetrical dimethylarginine, Conjunctivitis
Call sooner if
Escalation
Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.
Bottom line: Use this Gabapentin brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
- openFDA reaction aggregate term · adverse_reaction · adverse reactions
- Medication contraindications · safety_warning · warnings contraindications
- Structured Product Label · document · documents
- Structured Product Label · document · documents
- Structured Product Label · document · documents
- Structured Product Label · document · documents
Evidence
Review status / Updated / Sources
Review status: Clinical reviewer not listed
Updated: April 15, 2026, 10:04 AM UTC
Sources:
- Medication contraindications · safety_warning
- openFDA reaction aggregate term · adverse_reaction
- Structured Product Label · document
- Structured Product Label · document
- Structured Product Label · document
Safety & side effects
Side effects to monitor:
- Use caution with kidney disease
- dose adjustments may be needed
- Thrombocytopenia
- Elevated symmetrical dimethylarginine
- Conjunctivitis
Most reported reactions:
- Thrombocytopenia (4 reports)
- Elevated symmetrical dimethylarginine (4 reports)
- Conjunctivitis (3 reports)
Emergency warning signs:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Vet Fast Scan
Source-backed clinical checkpoints for quick review.
FDA-labeled species
Not linked yet
Indication / use
Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.
Form / route / dose
Confirm product label and patient-specific plan.
Warnings
- High: Use caution with kidney disease; dose adjustments may be needed.
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs
- Gabapentin SPL SPL
- Gabapentin SPL SPL
- SolutitionKits SPL SPL
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Species: Both
Manufacturer: Multiple FDA labelers
Identifiers:
NDC Package: 46144-600-01
NDC Package: 62157-711-01
NDC Package: 73377-176-01
NDC Package: 86032-041-01
NDC Product: 46144
NDC Product: 62157
NDC Product: 73377
NDC Product: 86032
Warnings / Contraindications
Use caution with kidney disease; dose adjustments may be needed.
- High: Use caution with kidney disease; dose adjustments may be needed.
Source metadata:
- https://animaldrugsatfda.fda.gov · safety_warning · Medication contraindications
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Reported case explorer
Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
164
Matching reports
18
Active filters
1
Selected filters
Reaction: Intentional misuse
Clear
Drill into common report signals
Showing up to 50 matching reports.
USA-USFDACVM-2026-US-013761
Received 2026-03-24 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Longhair
- Size / weight
- Under 10 lb (2.781 Kilogram)
- Age
- Under 1 year (5 Month)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Increased respiratory rateBreathing difficultyCrackles on auscultationAbnormal ultrasound findingPulmonary disorder NOSIntentional misuseDecreased pulse oxygenationPale mucous membrane
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-012798
Received 2026-03-20 · MSK · MSK
- Species
- Dog
- Breed
- Crossbred Canine/dog
- Size / weight
- 25-49 lb (14.969 Kilogram)
- Age
- 1-3 years (1 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- VocalisationRestlessnessIntentional misuse
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-013537
Received 2026-03-16 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Longhair
- Size / weight
- Under 10 lb (4.47 Kilogram)
- Age
- 4-7 years (7 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Localised hair lossReddening of the skinItchy skinWoundDermal thickeningAbnormal cytologyIntentional misuseLocal swelling (not application site)Reverse sneezingLeukocytosis NOSThrombocytopeniaNeutrophiliaMonocytosisSkin lesion NOS
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-012640
Received 2026-03-16 · MSK · MSK
- Species
- Dog
- Breed
- Chihuahua
- Size / weight
- Under 10 lb (2.54 Kilogram)
- Age
- 8+ years (8.25 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Muscle tremorOpisthotonusRigidity of limbsStar-gazingProlonged anaesthesiaIntentional misuse
- Body systems
- NeurologicOther
- Outcomes
- Recovered/Normal
USA-USFDACVM-2026-US-011382
Received 2026-03-10 · MSK · MSK
- Species
- Dog
- Breed
- Dog (unknown)
- Size / weight
- 25-49 lb (15.286 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Lack of efficacy - NOSIntentional misuse
- Body systems
- EffectivenessOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-010748
Received 2026-03-04 · MSK · MSK
- Species
- Dog
- Breed
- ['Terrier - Bull - American Pit', 'Terrier - Bull - Staffordshire']
- Size / weight
- 25-49 lb (21.22 Kilogram)
- Age
- Under 1 year (9 Month)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Skin lumpSurgical site disorderSkin inflammation NOSReddening of the skinIntentional misuseApplication site irritationApplication site reddeningApplication site inflammationContamination NOS
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-009973
Received 2026-02-27 · MSK · MSK
- Species
- Dog
- Breed
- Crossbred Canine/dog
- Size / weight
- 50-99 lb (34.019 Kilogram)
- Age
- 8+ years (10.5 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Not eatingWalking difficultyPantingSeizure NOSDeathIntentional misuse
- Body systems
- OtherNeurologic
- Outcomes
- Died
USA-USFDACVM-2026-US-010698
Received 2026-02-24 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6.427 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- PruritusSkin lesion NOSSkin scabLabeled drug-species interactionIntentional misuse
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-010994
Received 2026-02-23 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.874 Kilogram)
- Age
- 1-3 years (2 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Blood clotIntentional misuse
- Body systems
- Other
- Outcomes
- Outcome Unknown
USA-USFDACVM-2026-US-006203
Received 2026-02-10 · MSK · MSK
- Species
- Dog
- Breed
- Mountain Dog - Bernese
- Size / weight
- 50-99 lb (35.698 Kilogram)
- Age
- 4-7 years (7 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Lethargy (see also Central nervous system depression in Neurological)InappetenceSwollen lip (see also Skin)Localised pain NOS (see other SOCs for specific pain)Ocular dischargeNot drinkingSmelly breathLip smackingWalking difficultyAbdominal painDrooping eyelidReluctant to moveOral ulcerationTongue ulcerationIntentional misuse
- Body systems
- NeurologicOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-007418
Received 2026-02-09 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (8.7 Kilogram)
- Age
- 1-3 years (2.8 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Lack of efficacy - NOSNot eatingLethargy (see also Central nervous system depression in Neurological)General pain (see other SOCs for specific pain)Facial oedemaTrigeminus paralysisOral ulcerationIntentional misuse
- Body systems
- EffectivenessOtherNeurologic
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-003352
Received 2026-01-27 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.992 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- DiarrhoeaDecreased appetiteLethargy (see also Central nervous system depression in Neurological)Bloody diarrhoeaDry mucous membraneOpen mouth breathingUnresponsive to stimuliDecreased haematocritIncreased percentage reticulocytesRegenerative anaemiaIntentional misuseThrombocytopeniaHypersalivationHeart murmur
- Body systems
- DigestiveNeurologicOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-072888
Received 2025-12-11 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Longhair
- Size / weight
- 10-24 lb (5.715 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- SyncopeCollapse NOS (see also Cardio-vascular and Neurological disorders)AnorexiaHidingLow blood pressureHepatomegalyHepato-biliary disorder NOSIntentional misuse
- Body systems
- OtherNeurologicDigestive
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-072814
Received 2025-12-10 · MSK · MSK
- Species
- Dog
- Breed
- Pinscher - Miniature
- Size / weight
- Under 10 lb (4.037 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Lethargy (see also Central nervous system depression in Neurological)TremblingLimpingHead downWalking difficultyFeverLack of efficacy - NOSElevated globulinsBlood in urineImmune-mediated polyarthropathyElevated protein:creatinine ratioProteinuriaIntentional misuse
- Body systems
- NeurologicOtherEffectiveness
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-069596
Received 2025-11-24 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6.2 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Not eatingVomitingCardiac enlargementSplenomegalyAbnormal ultrasound findingHaematuriaPyuriaNon-regenerative anaemiaDecreased haematocritHypokalaemiaBladder distensionDehydrationElevated creatinineNot urinatingIntentional misuseUrinary tract disorder NOS
- Body systems
- OtherDigestive
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-067364
Received 2025-11-14 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6.804 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- DehydrationEmesis (multiple)Elevated cholesterol (total)Abnormal radiograph findingLack of efficacy - NOSWeaknessUrinary incontinenceAtaxiaDullRecumbencyIncreased coagulation timeElevated aspartate aminotransferase (AST)Elevated creatinineHypokalaemiaElevated gamma-glutamyl transferase (GGT)Elevated triglycerideBlood in urineHypothermiaDisseminated intravascular coagulationCardiorespiratory arrestDeathIntentional misuseShockDistension of abdomen
- Body systems
- OtherDigestiveEffectivenessNeurologic
- Outcomes
- Died
USA-USFDACVM-2025-US-067000
Received 2025-11-14 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.992 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- DiarrhoeaDecreased appetiteLethargy (see also Central nervous system depression in Neurological)Bloody diarrhoeaDry mucous membraneOpen mouth breathingUnresponsive to stimuliDecreased haematocritIncreased percentage reticulocytesRegenerative anaemiaIntentional misuseUnderdoseThrombocytopeniaHeart murmurHypersalivation
- Body systems
- DigestiveNeurologicOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-069686
Received 2025-11-12 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.9 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Swollen limbEpistaxisDeath by euthanasiaMalaiseHeart murmurNeutropeniaThrombocytopeniaHypoalbuminaemiaIncreased drinkingHaematuriaDecreased urine concentrationElevated protein:creatinine ratioDehydrationLymphopeniaAbdominal painIntestinal disorder NOSAbnormal radiograph findingRenal failureRenal disorder NOSInflammatory bowel disorderBronchopulmonary inflammationBruisingAnaemia NOSTachycardiaPale mucous membraneElevated alanine aminotransferase (ALT)Prolonged one stage prothrombin time (OSPT)Intentional misuseMedication error NOSPolyuriaAnorexiaAzotaemiaNecropsy performedHaemorrhage NOSFractureThyroid adenomaPancreas disorder
- Body systems
- OtherDigestive
- Outcomes
- Euthanized
Tap or hover a reaction to see what it means in plain language.
Tracked signals
32
Reported cases
60
Serious reports
7
Species represented
2
Grouped by Body System
Effectiveness (1)
· Lack of efficacy (endoparasite) - tapeworm
Other (31)
· Thrombocytopenia, Elevated symmetrical dimethylarginine, Conjunctivitis
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Other | 4 | Dog | 0 | |
| Other | 4 | Dog | 0 | |
| Other | 3 | Dog | 0 | |
| Other | 2 | Dog | 0 | |
| Other | 2 | Dog | 0 | |
| Other | 2 | Dog | 0 | |
| Other | 2 | Dog | 0 | |
| Other | 2 | Dog | 0 |
Species coverage: Dog (48) Cat (12)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Other | Dog | Unknown | - | 4 | |
| Other | Dog | Unknown | - | 4 | |
| Other | Dog | Unknown | - | 3 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Effectiveness | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Unknown | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 |
Source metadata:
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA reaction aggregate term
Storage & Handling
Store at room temperature.
Source Documents
The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.
Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.
Gabapentin SPL
SPL · Structured Product Label
Gabapentin SPL
SPL · Structured Product Label
SolutitionKits SPL
SPL · Structured Product Label
Full source previews and metadata remain in the veterinary/professional layer.
Owner handouts
0No owner handouts linked yet.
Official label / PI
0No official label or package insert links yet.
SPL
4FOI
0No FOI links yet.
Gabapentin SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Gabapentin. Use the source link for the full official labeling record.
Gabapentin SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Gabapentin. Use the source link for the full official labeling record.
SolutitionKits SPL
SPL · Structured Product Label
FDA Structured Product Label XML for SolutitionKits. Use the source link for the full official labeling record.
GABAPENTIN SPL
SPL · Structured Product Label
FDA Structured Product Label XML for GABAPENTIN. Use the source link for the full official labeling record.
Source metadata:
- https://www.accessdata.fda.gov/spl/data/54945492-2e86-4f6d-99e0-d4f492ab0dc0/54945492-2e86-4f6d-99e0-d4f492ab0dc0.xml · document · Structured Product Label
- https://www.accessdata.fda.gov/spl/data/de14dc38-395f-420b-89b9-f3c57e195149/de14dc38-395f-420b-89b9-f3c57e195149.xml · document · Structured Product Label
- https://www.accessdata.fda.gov/spl/data/fc8d67a9-6118-481c-a1e4-53269e18b31d/fc8d67a9-6118-481c-a1e4-53269e18b31d.xml · document · Structured Product Label
- https://www.accessdata.fda.gov/spl/data/346c35fb-8599-4556-9804-a4452af8bb91/346c35fb-8599-4556-9804-a4452af8bb91.xml · document · Structured Product Label
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
Data freshness
-
Reference facts:
Source Roxee
| Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Aug 6, 2026, 7:47 PM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient
• FDA branded products available
Official FDA brands:
GABAPENTIN
Gabapentin
SolutitionKits
Manufacturer mapping:
Multiple FDA labelers
Case-reported brands (openFDA):
MSK
Catalog species: Both
NDC:
Packages
46144-600-01
62157-711-01
73377-176-01
86032-041-01
•
Products
46144
62157
73377
86032
Explore
Related conditions:
Pain (acute, chronic)
Linked using:
Usage_Inferred (0.78)
Diagnosis Codes
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Owner-facing counseling points
- Use caution with kidney disease; dose adjustments may be needed. (Contraindication, High)
Top reaction signals
Thrombocytopenia (4)
Elevated symmetrical dimethylarginine (4)
Conjunctivitis (3)
Urolithiasis (2)
Unclassifiable adverse event (2)
Trembling (2)
Skin lesion NOS (2)
Respiratory tract infection NOS (2)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
Identifiers
NDC Package: 46144-600-01
NDC Package: 62157-711-01
NDC Package: 73377-176-01
NDC Package: 86032-041-01
NDC Product: 46144
NDC Product: 62157
NDC Product: 73377
NDC Product: 86032
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 46144-600-01 | 46144 | - | |
| 62157-711-01 | 62157 | - | |
| 73377-176-01 | 73377 | - | |
| 86032-041-01 | 86032 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
Gabapentin SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Gabapentin SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
SolutitionKits SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
GABAPENTIN SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
Official 4
Clinical 120
Manufacturer 0
Marketing 0
Marketing/Manufacturer content exists: 1 linked manufacturer ad video are attached to this medication.
Current Field Facts
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-20)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-19)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-16)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-16)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-13)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-12)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-10)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-07)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-06)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-06)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-03)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-03)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-02)
- contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-01)
Recent Revisions
- side_effects updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|
Data source: FDA Animal Drugs @ FDA (public search export).
Usage
Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.
Contraindications
Use caution with kidney disease; dose adjustments may be needed.
Side Effects
Sedation, ataxia, mild GI upset.
Source: FDA openFDA • Reference
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Effectiveness
Lack of efficacy (endoparasite) - tapeworm (2)
• Dog
Showing top 5 for Effectiveness.
Other
Thrombocytopenia (4)
• Dog
Elevated symmetrical dimethylarginine (4)
• Dog
Conjunctivitis (3)
• Dog
Urolithiasis (2)
• Dog
Unclassifiable adverse event (2)
• Dog
Show more (26)
Trembling (2)
• Dog
Skin lesion NOS (2)
• Dog
Respiratory tract infection NOS (2)
• Dog
Regurgitation (2)
• Dog
Reduced globulins (2)
• Dog
Pyoderma (2)
• Dog
Proprioception deficit (2)
• Dog
Knuckling (2)
• Dog
Hypophosphataemia (2)
• Dog
Hypokalaemia (2)
• Cat
Hepatomegaly (2)
• Cat
Fracture (2)
• Dog
Erythema (2)
• Dog
Elevated alanine aminotransferase (2)
• Cat
Decreased activity (2)
• Cat
Death (2)
• Cat
Confusion (2)
• Dog
Abnormal radiograph finding (1)
• Cat
Abnormal movement NOS (1)
• Dog
Abnormal menace reflex test (1)
• Cat
Abnormal histology NOS (1)
• Dog
Abnormal cytology (1)
• Dog
Abdominal pain (1)
• Dog
Abdominal effusion (1)
• Dog
Abdominal discomfort (1)
• Dog
Abdominal cavity disorder NOS (1)
• Dog
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Domestic Shorthair, Female, 11 year, 3.992 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Facial pruritus, Medication error NOS • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2026-US-014454
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 11.00 Year
- Weight: 3.992 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Unassigned
Reactions Reported:
Facial pruritus
Medication error NOS
Outcomes: Recovered/Normal
Dog, Retriever - Labrador, Male, 11 year, 47.174 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Partial lack of efficacy • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-014361
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 11.00 Year
- Weight: 47.174 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Partial lack of efficacy
Outcomes: Ongoing
Dog, Schnauzer - Miniature, Male, 5 year, 10.16 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Lameness, Wobbliness, Tiredness (lethargy), Unable to walk, Weakness… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-014449
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 5.00 Year
- Weight: 10.160 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Unassigned
Reactions Reported:
Lameness
Wobbliness
Tiredness (lethargy)
Unable to walk
Weakness
Fever
Immune-mediated polyarthritis
Gastritis
Abdominal cavity disorder NOS
Abnormal ultrasound finding
Hyperproteinaemia
Lymphopenia
Eosinopenia
Medication error NOS
Outcomes: Ongoing
Dog, Crossbred Canine/dog, Male, 10 year, 32.205 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Musculoskeletal disorder NOS, Aggression, Unable to walk, Urinary incontinence, Melaena… • Outcome: Euthanized
- Report ID: USA-USFDACVM-2026-US-014374
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 10.00 Year
- Weight: 32.205 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Musculoskeletal disorder NOS
Aggression
Unable to walk
Urinary incontinence
Melaena
Vomiting
Tiredness (lethargy)
Death by euthanasia
Neurological signs NOS
Outcomes: Euthanized
Dog, Retriever - Labrador, Unknown • Drug: MSK, Unknown • Reactions: Death • Outcome: Died
- Report ID: USA-USFDACVM-2026-US-014204
- Serious AE: Yes
- Treated For AE: No
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Death
Outcomes: Died
Cat, Domestic Shorthair, Female, 20 year, 2.631 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Agitation, Vocalisation, Unsteady walking (ataxia), Weakness • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2026-US-014011
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 20.00 Year
- Weight: 2.631 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Agitation
Vocalisation
Unsteady walking (ataxia)
Weakness
Outcomes: Recovered/Normal
Dog, Retriever - Golden, Female, 4 year, 34.019 kilogram • Drug: MSK, Unassigned, Unknown, Dose: 300 Milligram per animal, Frequency: 12 per hour • Reactions: Lameness, Difficulty to rise, Joint swelling, Abnormal radiograph finding, Bone and joint disorder NOS… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-014065
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 4.00 Year
- Weight: 34.019 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
- Dose: 300 Milligram per animal
- Frequency: 12 per hour
Reactions Reported:
Lameness
Difficulty to rise
Joint swelling
Abnormal radiograph finding
Bone and joint disorder NOS
Discomfort NOS
Outcomes: Ongoing
Dog, Shepherd Dog - German, Female, 9 year, 35.698 kilogram • Drug: MSK, Unassigned, Oral, Dose: 200 Milligram per animal, Frequency: 12 per hour • Reactions: Joint pain, Lameness, Depression, Difficulty standing, Decreased appetite… • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2026-US-014048
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 9.00 Year
- Weight: 35.698 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Unassigned
- Dose: 200 Milligram per animal
- Frequency: 12 per hour
Reactions Reported:
Joint pain
Lameness
Depression
Difficulty standing
Decreased appetite
Abnormal radiograph finding
Bone and joint disorder NOS
Joint effusion
Spondylosis
Outcomes: Outcome Unknown
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
Overdose can cause severe sedation, loss of coordination, muscle tremors, and respiratory depression. Emergency care: IV fluids, monitoring.
Storage & Handling
Store at room temperature.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
No community reviews yet. Be the first to share your experience.
This medication has not been reviewed by a veterinarian yet.
Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.